Neurocrine's market cap is currently $11.36B. The company's EPS TTM is $3.291; its P/E ratio is 34.72; Neurocrine is scheduled to report earnings on February 11, 2025, and the estimated EPS forecast is $0.86. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
Income Statement
Total Revenue	$ 2.36B	$ 1.89B	$ 1.49B	$ 1.13B	$ 1.05B
Gross Profit	$ 2.32B	$ 1.85B	$ 1.47B	$ 1.12B	$ 1.04B
Operating Income	$ 570.50M	$ 250.90M	$ 249.00M	$ 196.90M	$ 318.90M
EBITDA	$ 610.10M	$ 358.00M	$ 264.60M	$ 218.70M	$ 336.10M
Net Income	$ 341.30M	$ 249.70M	$ 154.50M	$ 89.60M	$ 407.30M
Balance Sheet
Cash & Short-Term Investments	$ 1.08B	$ 1.03B	$ 989.30M	$ 711.30M	$ 801.00M
Total Assets	$ 3.72B	$ 3.25B	$ 2.37B	$ 2.07B	$ 1.73B
Total Debt	$ 455.10M	$ 428.40M	$ 262.90M	$ 440.40M	$ 412.30M
Net Debt	$ 222.10M	$ 177.30M	$ 0.00	$ 99.60M	$ -388.70M
Total Liabilities	$ 1.13B	$ 1.02B	$ 660.90M	$ 698.50M	$ 608.50M
Stockholders' Equity	$ 2.59B	$ 2.23B	$ 1.71B	$ 1.37B	$ 1.13B
Cash Flow
Free Cash Flow	$ 557.20M	$ 361.60M	$ 322.90M	$ 233.10M	$ 217.60M
Operating Cash Flow	$ 595.40M	$ 389.90M	$ 339.40M	$ 256.50M	$ 228.50M
Investing Cash Flow	$ -126.80M	$ -467.10M	$ -177.10M	$ -130.20M	$ 4.10M
Financing Cash Flow	$ -486.70M	$ 65.30M	$ -234.30M	$ 27.40M	$ -157.80M

Currency in USD

Neurocrine Earnings and Revenue History

Income Statement >

Neurocrine Debt to Assets

Balance Sheet >

Neurocrine Cash Flow

Cash Flow >

Neurocrine Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing